Six-year study on peripheral venous catheter–associated BSI rates in 262 ICUs in eight countries of South-East Asia: International Nosocomial Infection Control Consortium findings

Abstract

Background:

Short-term peripheral venous catheter–associated bloodstream infection rates have not been systematically studied in Asian countries, and data on peripheral venous catheter–associated bloodstream infections incidence by number of short-term peripheral venous catheter days are not available.

Methods:

Prospective, surveillance study on peripheral venous catheter–associated bloodstream infections conducted from 1 September 2013 to 31 May 2019 in 262 intensive care units, members of the International Nosocomial Infection Control Consortium, from 78 hospitals in 32 cities of 8 countries in the South-East Asia Region: China, India, Malaysia, Mongolia, Nepal, Philippines, Thailand, and Vietnam. For this research, we applied definition and criteria of the CDC NHSN, methodology of the INICC, and software named INICC Surveillance Online System.

Results:

We followed 83,295 intensive care unit patients for 369,371 bed-days and 376,492 peripheral venous catheter-days. We identified 999 peripheral venous catheter–associated bloodstream infections, amounting to a rate of 2.65/1000 peripheral venous catheter-days. Mortality in patients with peripheral venous catheter but without peripheral venous catheter–associated bloodstream infections was 4.53% and 12.21% in patients with peripheral venous catheter–associated bloodstream infections. The mean length of stay in patients with peripheral venous catheter but without peripheral venous catheter–associated bloodstream infections was 4.40 days and 7.11 days in patients with peripheral venous catheter and peripheral venous catheter–associated bloodstream infections. The microorganism profile showed 67.1% were Gram-negative bacteria: Escherichia coli (22.9%), Klebsiella spp (10.7%), Pseudomonas aeruginosa (5.3%), Enterobacter spp. (4.5%), and others (23.7%). The predominant Gram-positive bacteria were Staphylococcus aureus (11.4%).

Conclusions:

Infection prevention programs must be implemented to reduce the incidence of peripheral venous catheter–associated bloodstream infections.

Keywords

Hospital infection device-associated infections antibiotic resistance peripheral line–associated bloodstream infections mortality intensive care unit surveillance

Get full access to this article

View all access options for this article.

References

Helm

Klausner

Klemperer

, et al. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs 2019; 42: 151–164.

Sabri

Szalas

Holmes

, et al. Failed attempts and improvement strategies in peripheral intravenous catheterization. Biomed Mater Eng 2013; 23(1–2): 93–108.

Mermel

. Short-term peripheral venous catheter-related bloodstream infections: a systematic review. Clin Infect Dis 2017; 65: 1757–1762.

Zhang

Cao

Marsh

, et al. Infection risks associated with peripheral vascular catheters. J Infect Prev 2016; 17(5): 207–213.

Wallis

McGrail

Webster

, et al. Risk factors for peripheral intravenous catheter failure: a multivariate analysis of data from a randomized controlled trial. Infect Control Hosp Epidemiol 2014; 35(1): 63–68.

Alexandrou

Ray-Barruel

Carr

, et al. Use of short peripheral intravenous catheters: characteristics, management, and outcomes worldwide. J Hosp Med 2018; 13(5): E1–E7.

Rosenthal

Al-Abdely

El-Kholy

, et al. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: device-associated module. Am J Infect Control 2016; 44(12): 1495–1504.

Rosenthal

Lynch

Jarvis

, et al. Socioeconomic impact on device-associated infections in limited-resource neonatal intensive care units: findings of the INICC. Infection 2011; 39(5): 439–450.

Rosenthal

Jarvis

Jamulitrat

, et al. Socioeconomic impact on device-associated infections in pediatric intensive care units of 16 limited-resource countries: International Nosocomial Infection Control Consortium findings. Pediatr Crit Care Med 2012; 13(4): 399–406.

10.

Abolfotouh

Salam

Bani-Mustafa

, et al. Prospective study of incidence and predictors of peripheral intravenous catheter-induced complications. Ther Clin Risk Manag 2014; 10: 993–1001.

11.

Maki

Kluger

Crnich

. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006; 81(9): 1159–1171.

12.

Worth

Daley

Spelman

, et al. Central and peripheral line-associated bloodstream infections in Australian neonatal and paediatric intensive care units: findings from a comprehensive Victorian surveillance network, 2008-2016. J Hosp Infect 2018; 99(1): 55–61.

13.

Rosenthal

. International Nosocomial Infection Control Consortium (INICC) resources: INICC multidimensional approach and INICC surveillance online system. Am J Infect Control 2016; 44(6): e81–e90.

14.

National Healthcare Safety Network (NHSN). Patient safety component manual: Centers for Disease Control and Prevention, 2019, https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf

15.

CDC/NHSN. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting, http://www.cdc.gov/nhsn/ (2019, accessed 6 July 2019).

16.

CDC/NHSN. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. http://www.cdc.gov/nhsn/ (2017, accessed 6 March 2017).

17.

18.

19.

Ray-Barruel

Marsh

, et al. Effectiveness of insertion and maintenance bundles in preventing peripheral intravenous catheter-related complications and bloodstream infection in hospital patients: a systematic review. Infect Dis Health 2019; 24: 152–168.

20.

Rhodes

Cheng

McLellan

, et al. Reducing Staphylococcus aureus bloodstream infections associated with peripheral intravenous cannulae: successful implementation of a care bundle at a large Australian health service. J Hosp Infect 2016; 94(1): 86–91.

21.

Salm

Schwab

Geffers

, et al. The implementation of an evidence-based bundle for bloodstream infections in neonatal intensive care units in Germany: a controlled intervention study to improve patient safety. Infect Control Hosp Epidemiol 2016; 37(7): 798–804.

22.

Saliba

Hornero

Cuervo

, et al. Interventions to decrease short-term peripheral venous catheter-related bloodstream infections: impact on incidence and mortality. J Hosp Infect 2018; 100(3): e178–e186.

23.

Freixas

Bella

Limon

, et al. Impact of a multimodal intervention to reduce bloodstream infections related to vascular catheters in non-ICU wards: a multicentre study. Clin Microbiol Infect 2013; 19(9): 838–844.

24.

DeVries

Valentine

Mancos

. Protected clinical indication of peripheral intravenous lines: successful implementation. J Assoc Vasc Access 2016; 21: 89–92.

25.

Duncan

Warden

Bernatchez

, et al. A bundled approach to decrease the rate of primary bloodstream infections related to peripheral intravenous catheters. J Assoc Vasc Access 2018; 23: 15–22.

26.

Mehta

Jaggi

Rosenthal

, et al. Device-associated infection rates in 20 cities of India, data summary for 2004-2013: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol 2016; 37(2): 172–181.

27.

Sato

Nakamura

Fujita

, et al. Peripheral venous catheter-related bloodstream infection is associated with severe complications and potential death: a retrospective observational study. BMC Infect Dis 2017; 17(1): 434–434.

28.

Elsayed

Laupland

. Emerging Gram-positive bacterial infections. Clin Lab Med 2004; 24: 587–603.

29.

Dalai

Padhi

, et al. Peripheral venous catheter related blood stream infection in intensive care unit. Int J Adv Med 2018; 5: 668–673.

30.

Rosenthal

Maki

Graves

. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control 2008; 36(9): e1–e12.

31.

Centers for Disease Control and Prevention. The NHSN standardized utilization ratio (SUR): a guide to the SUR, https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/nhsn-sur-guide-508.pdf (2019, accessed 25 January 2019).

32.

Centers for Disease Control and Prevention. The NHSN standardized infection ratio (SIR): a guide to the SIR, https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/nhsn-sir-guide.pdf (2019, accessed 27 May 2019).